AI assistant
Citi Pharma Ltd. M&A Activity 2025
71782_rns_2025-04-16_e1b5cb5d-4d2c-4ef3-81a2-609c970e7c76.pdf
M&A Activity
Open in viewerOpens in your device viewer
Citi Pharma Lirnited
APRIL 16, 2025
The General Manager, Pakistan Stock Exchange Limited, Stock Exchange Building, Stock Exchange Road, Karachi
Subject: SUBMISSION OF NON-BINDING OFFER FOR POTENTIAL ACQUISITION
Dear Sir,
In accordance with Section 96 of the Securities Act, 2015 and Clause 5.6.1 of the PSX Rule Book, we would like to inform the Pakistan Stock Exchange and our valued shareholders that:
Citi Pharma Limited has submitted a Non-Binding Offer for the potential acquisition of a leading pharmaceuticals company in Pakistan.
The submission of the non-binding offer is part of our ongoing strategic expansion plans of the Company to become one of the largQst players in the pharma industry of Pakistan.
Any further developments will be subject to the outcome of the due diligence process and subsequent approval(s) by the Board of Directors and relevant regulatory authorities.
The Company remains committed to keeping the Exchange and shareholders informed of any material developments in this regard.
For any further infoFmation or clarification, please feel free to contact the undersigned.
Sincerely, + =' Ghulam D@ed Company Secretar} Citi Pharma Limited
@b
588 - QI Johar Townl Lahore - Pakisatn Pi\$* 3KM. Head Balloki Road, Phool Nagar, District Kasur - Pakistan